Leonardo Brunetti

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Topics

Molecular Docking

Top Venues

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Leonardo Brunetti, Fabio Francavilla, Marcello Leopoldo, Enza Lacivita
Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Vincenzo Roselli, Gianluca Pugliese, Rosalba Leuci, Leonardo Brunetti, Lucia Gambacorta, Vincenzo Tufarelli, Luca Piemontese
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy. Molecules (Basel, Switzerland) 29 (11) (2024)
Vincenzo Roselli, Gianluca Pugliese, Rosalba Leuci, Leonardo Brunetti, Lucia Gambacorta, Vincenzo Tufarelli, Luca Piemontese
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy. Molecules (Basel, Switzerland) 29 (11) (2024)
Leonardo Brunetti, Fabio Francavilla, Marcello Leopoldo, Enza Lacivita
Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Vincenzo Roselli, Gianluca Pugliese, Rosalba Leuci, Leonardo Brunetti, Lucia Gambacorta, Vincenzo Tufarelli, Luca Piemontese
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy. Molecules (Basel, Switzerland) 29 (11) (2024)
David Vicente-Zurdo, Leonardo Brunetti, Luca Piemontese, Beatriz F S Guedes, Sandra Morais Cardoso, Daniel Chavarria, Fernanda Borges, Yolanda Madrid, Silvia Chaves, Maria Amélia Santos
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases. International journal of molecular sciences 24 (9) (2023)
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Rosalba Leuci, Erica Pranzini, Alice Santi, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas, Ravi Pratap Singh, Suhas Tambe, Sudeep Ca, Ashok Kumar Pattnaik, Venkatesan Jayaprakash, Paolo Paoli, Antonio Lavecchia, Fulvio Loiodice
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition. Journal of medicinal chemistry 66 (5) (2023)
David Vicente-Zurdo, Leonardo Brunetti, Luca Piemontese, Beatriz F S Guedes, Sandra Morais Cardoso, Daniel Chavarria, Fernanda Borges, Yolanda Madrid, Silvia Chaves, Maria Amélia Santos
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases. International journal of molecular sciences 24 (9) (2023)
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Rosalba Leuci, Erica Pranzini, Alice Santi, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas, Ravi Pratap Singh, Suhas Tambe, Sudeep Ca, Ashok Kumar Pattnaik, Venkatesan Jayaprakash, Paolo Paoli, Antonio Lavecchia, Fulvio Loiodice
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition. Journal of medicinal chemistry (2023)
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Rosalba Leuci, Erica Pranzini, Alice Santi, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas, Ravi Pratap Singh, Suhas Tambe, Sudeep Ca, Ashok Kumar Pattnaik, Venkatesan Jayaprakash, Paolo Paoli, Antonio Lavecchia, Fulvio Loiodice
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition. Journal of medicinal chemistry 66 (5) (2023)
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Rosalba Leuci, Erica Pranzini, Alice Santi, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas, Ravi Pratap Singh, Suhas Tambe, Sudeep Ca, Ashok Kumar Pattnaik, Venkatesan Jayaprakash, Paolo Paoli, Antonio Lavecchia, Fulvio Loiodice
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition. Journal of medicinal chemistry 66 (5) (2023)
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Rosalba Leuci, Erica Pranzini, Alice Santi, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas, Ravi Pratap Singh, Suhas Tambe, Sudeep Ca, Ashok Kumar Pattnaik, Venkatesan Jayaprakash, Paolo Paoli, Antonio Lavecchia, Fulvio Loiodice
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition. Journal of medicinal chemistry (2023)
Francesca Intranuovo, Leonardo Brunetti, Pietro DelRe, Giuseppe Felice Mangiatordi, Angela Stefanachi, Antonio Laghezza, Mauro Niso, Francesco Leonetti, Fulvio Loiodice, Alessia Ligresti, Magdalena Kostrzewa, Jose Brea, Maria Isabel Loza, Eddy Sotelo, Alessandro Tossi, Nicola Antonio Colabufo, Chiara Riganti, Carmen Abate, Marialessandra Contino
Development of N -(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase. Journal of medicinal chemistry 66 (1) (2022)
Alessia Carocci, Alexia Barbarossa, Rosalba Leuci, Antonio Carrieri, Leonardo Brunetti, Antonio Laghezza, Marco Catto, Francesco Limongelli, Silvia Chaves, Paolo Tortorella, Cosimo Damiano Altomare, Maria Amélia Santos, Fulvio Loiodice, Luca Piemontese
Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer's Disease. Antioxidants (Basel, Switzerland) 11 (9) (2022)
Leonardo Brunetti, Rosalba Leuci, Maria Antonietta Colonna, Rossana Carrieri, Francesco Emanuele Celentano, Giancarlo Bozzo, Fulvio Loiodice, Maria Selvaggi, Vincenzo Tufarelli, Luca Piemontese
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding. Molecules (Basel, Switzerland) 27 (15) (2022)
David Vicente-Zurdo, Noelia Rosales-Conrado, María Eugenia León-González, Leonardo Brunetti, Luca Piemontese, A Raquel Pereira-Santos, Sandra Morais Cardoso, Yolanda Madrid, Silvia Chaves, Maria Amélia Santos
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease. Biomedicines 10 (7) (2022)
Francesca Intranuovo, Leonardo Brunetti, Pietro DelRe, Giuseppe Felice Mangiatordi, Angela Stefanachi, Antonio Laghezza, Mauro Niso, Francesco Leonetti, Fulvio Loiodice, Alessia Ligresti, Magdalena Kostrzewa, Jose Brea, Maria Isabel Loza, Eddy Sotelo, Alessandro Tossi, Nicola Antonio Colabufo, Chiara Riganti, Carmen Abate, Marialessandra Contino
Development of N -(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase. Journal of medicinal chemistry 66 (1) (2022)
Francesca Intranuovo, Leonardo Brunetti, Pietro DelRe, Giuseppe Felice Mangiatordi, Angela Stefanachi, Antonio Laghezza, Mauro Niso, Francesco Leonetti, Fulvio Loiodice, Alessia Ligresti, Magdalena Kostrzewa, Jose Brea, Maria Isabel Loza, Eddy Sotelo, Alessandro Tossi, Nicola Antonio Colabufo, Chiara Riganti, Carmen Abate, Marialessandra Contino
Development of N -(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase. Journal of medicinal chemistry (2022)
Rosalba Leuci, Leonardo Brunetti, Antonio Laghezza, Luca Piemontese, Antonio Carrieri, Leonardo Pisani, Paolo Tortorella, Marco Catto, Fulvio Loiodice
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE). Molecules (Basel, Switzerland) 27 (3) (2022)
Francesca Intranuovo, Leonardo Brunetti, Pietro DelRe, Giuseppe Felice Mangiatordi, Angela Stefanachi, Antonio Laghezza, Mauro Niso, Francesco Leonetti, Fulvio Loiodice, Alessia Ligresti, Magdalena Kostrzewa, Jose Brea, Maria Isabel Loza, Eddy Sotelo, Alessandro Tossi, Nicola Antonio Colabufo, Chiara Riganti, Carmen Abate, Marialessandra Contino
Development of N -(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase. Journal of medicinal chemistry 66 (1) (2022)
Antonio Laghezza, Luca Piemontese, Leonardo Brunetti, Alessia Caradonna, Mariangela Agamennone, Fulvio Loiodice, Paolo Tortorella
(2-Aminobenzothiazole)-Methyl-1,1-Bisphosphonic Acids: Targeting Matrix Metalloproteinase 13 Inhibition to the Bone. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Viviana Poliseno, Sílvia Chaves, Leonardo Brunetti, Fulvio Loiodice, Antonio Carrieri, Antonio Laghezza, Paolo Tortorella, João D Magalhães, Sandra M Cardoso, Maria Amélia Santos, Luca Piemontese
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer's Disease Agents. Biomolecules 11 (1) (2021)
Leonardo Brunetti, Antonio Carrieri, Luca Piemontese, Paolo Tortorella, Fulvio Loiodice, Antonio Laghezza
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors. International journal of molecular sciences 21 (19) (2020)
Rosalba Leuci, Leonardo Brunetti, Viviana Poliseno, Antonio Laghezza, Fulvio Loiodice, Paolo Tortorella, Luca Piemontese
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases. Foods (Basel, Switzerland) 10 (1) (2020)
Antonio Laghezza, Luca Piemontese, Leonardo Brunetti, Alessia Caradonna, Mariangela Agamennone, Antonella Di Pizio, Giorgio Pochetti, Roberta Montanari, Davide Capelli, Marilena Tauro, Fulvio Loiodice, Paolo Tortorella
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy. Pharmaceuticals (Basel, Switzerland) 13 (6) (2020)
Leonardo Brunetti, Fulvio Loiodice, Luca Piemontese, Paolo Tortorella, Antonio Laghezza
New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation. Journal of medicinal chemistry 62 (24) (2019)